About: Prospective randomized controlled trial on comparison of standard CO(2) pressure pneumoperitoneum insufflator versus AirSeal®

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prospective randomized controlled trial on comparison of standard CO(2) pressure pneumoperitoneum insufflator versus AirSeal® Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Prospective randomized controlled trial on comparison of standard CO(2) pressure pneumoperitoneum insufflator versus AirSeal®
Creator	Antoniou, Stavros Emmanuel, Klaus Knauer, Michael Koch, Owen Köhler, Gernot Könneker, Sören Luketina, L Luketina, Rosalia Manzenreiter, Lisa Oliver, · Theodore, · Wundsam, Helwig
Source	Medline; PMC
abstract	BACKGROUND: AirSeal® is a valve-free insufflation system that enables a stable pneumoperitoneum with continuous smoke evacuation and CO(2) recirculation during laparoscopic surgery. Comparative evidence on the use of AirSeal® and standard CO(2) insufflator in laparoscopic general surgery procedures is scarce. The aim of this study was to compare surgical outcomes between AirSeal® and standard CO(2) insufflators in patients undergoing the most frequently performed laparoscopic procedures. METHODS: One hundred and ninety-eight patients undergoing elective laparoscopic cholecystectomy, colorectal surgery and hernia repair were randomized to either AirSeal® (group A) or standard pressure CO(2) insufflator (group S). The primary endpoints were operative time and level of postoperative shoulder tip pain (Visual Analog Scale). Secondary outcomes included Clavien–Dindo grade complications, surgical side effect and length of hospital stay. RESULTS: Patients were randomized to either group A (n = 101) or group S (n = 97) and were analyzed by intention-to-treat. There was no significant difference in mean operative time between the groups (median [IQR]; 71 min [56–94] in group A vs. 69 min [52–93] in group S; p = 0.434). Shoulder tip pain levels were significantly lower in group S (VAS 0 [0–3] in group S vs. 2 [0–4] in group A; p = 0.001). There was no significant difference in complications, surgical side effects (subcutaneous emphysema was not observed in any group) and length of hospital stay. CONCLUSION: This randomized controlled trial showed that using the AirSeal® system did not reduce operative time and was associated with a higher postoperative shoulder tip pain compared to standard CO(2) insufflator for short elective surgeries. ClinicalTrials.gov (NCT01740011).
has issue date	2020-08-07(xsd:dateTime)
bibo:doi	10.1007/s00464-020-07846-4
bibo:pmid	32767145
has license	cc-by
sha1sum (hex)	69d982cfea43e4dc7e60197d3e4958b5d6459d67
schema:url	https://doi.org/10.1007/s00464-020-07846-4
resource representing a document's title	Prospective randomized controlled trial on comparison of standard CO(2) pressure pneumoperitoneum insufflator versus AirSeal®
has PubMed Central identifier	PMC7412773
has PubMed identifier	32767145
schema:publication	Surg Endosc
resource representing a document's body	covid:69d982cfea43e4dc7e60197d3e4958b5d6459d67#body_text
is schema:about of	named entity 'group' named entity 'time' named entity 'surgical' named entity 'surgical' named entity 'study' named entity 'randomized' named entity 'time' named entity 'insufflation' named entity 'side effects' named entity 'colorectal surgery' named entity 'median' named entity 'standard' named entity 'DID' named entity 'ONE HUNDRED AND NINETY' named entity 'ENDPOINTS' named entity 'METHODS' named entity 'DIFFERENCE' named entity 'MEAN' named entity 'INSUFFLATOR' named entity 'INCLUDED' named entity 'REDUCE' named entity 'SURGICAL' named entity 'FREE' named entity 'evidence' named entity 'endpoints' named entity 'continuous' named entity 'time' named entity 'laparoscopic' named entity 'group' named entity 'evacuation' named entity 'standard pressure' named entity 'IQR' named entity 'compared' named entity 'group' named entity 'Secondary' named entity 'stable' named entity 'group A' named entity 'frequently' named entity 'min' named entity 'short' named entity 'insufflation' named entity 'hernia repair' named entity 'laparoscopic surgery' named entity 'laparoscopic procedures' named entity 'insufflator' named entity 'laparoscopic surgery' named entity 'surgical instruments' named entity 'informed consent' named entity 'insufflator' named entity 'insufflation' named entity 'insufflation' named entity 'pregnancy' named entity 'systemic absorption' named entity 'intra-abdominal' named entity 'randomized controlled trials' named entity 'sample size' named entity 'pediatric' named entity 'sample size' named entity 'pneumoperitoneum' named entity 'insufflator' named entity 'laparoscopic surgery' named entity 'Metamizol' named entity 'colorectal surgery' named entity 'thrombotic disease' named entity 'laparoscopic' named entity 'intraperitoneal' named entity 'pneumoperitoneum' named entity 'laparoscopic cholecystectomy' named entity 'blood flow' named entity 'insufflator'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software